Acute and Chronic Administration of the Selective 5-HT1A Receptor Antagonist WAY-405 Significantly Alters the Activity of Midbrain Dopamine Neurons in Rats: An In Vivo Electrophysiological Study

Synapse

Volumn 50, Issue 3, 2003, Pages 181-190

  Minabe, Yoshio ^a,b   Schechter, Lee ^c   Hashimoto, Kenji ^b   Shirayama, Yuhiko ^b   Ashby Jr , Charles R ^d  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c PFIZER INC   (United States)

^d ST JOHN'S UNIVERSITY   (United States)

Author keywords

5 HT1A receptors; Dopamine neurons; In vivo electrophysiology; WAY 405

Indexed keywords

APOMORPHINE; SEROTONIN 1A ANTAGONIST; UNCLASSIFIED DRUG; WAY 405;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG SELECTIVITY; ELECTROPHYSIOLOGY; IN VIVO STUDY; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; SPIKE; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; DOPAMINE; ELECTROPHYSIOLOGY; MALE; MESENCEPHALON; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0142231880     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10255     Document Type: Article

References (35)

1. 1A receptor selective ligands, R-8-OH-DPAT and S-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn Schmied Arch Pharmacol 347:353-362.
2. Ashby Jr CR, Wang RY. 1996. Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24:349-394.
3. Ashby Jr CR, Minabe Y, Granoff M, Wang RY. 1994. The effect of acute and chronic administration of BRL 46470A, a potent and selective 5-HT3 receptor antagonist, on spontaneously active midbrain dopaminergic cells in the rat. Drug Dev Res 31:228-236.
4. 1 receptor antagonist CP 96,345 on midbrain DA neurons: an in vivo electrophysiological study. Synapse 22:35-45.
5. Bunney BS, Aghajanian GK. 1975. Antipsychotic drugs and central dopaminergic neurons: a model for predicting therapeutic efficacy and incidence of extrapyramidal side effects. In: Sudilovsky A, Gershon S, Beer B, editors. Predictability in psychopharmacology: preclinical and clinical correlations. New York: Raven Press. p 225-245.
6. Bunney BS, Grace AA. 1978. Acute and chronic haloperidol treatment: comparison of effects of nigral dopaminergic cell activity. Life Sci 23:1715-1728.
7. Bunney BS, Walter JR, Roth RH, Aghajanian GK. 1973. Dopaminergic neurons: effect of antipsychotic drugs and amphetamines on single cell activity. J Pharmacol Exp Ther 175:560-571.
8. Chiodo LA. 1988. Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neurosci Biobehav Rev 12:49-91.
9. Chiodo LA, Bunney BS. 1983. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 dopamine neurons. J Neurosci 7:1607-1619.
10. Doherty MD, Pickel VM. 2000. Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res 864:176-185.
11. 1A receptor antagonist. Behav Brain Res 73:337-353.
12. Freeman AS, Bunney BS. 1987. Chronic neuroleptic effects on dopamine neuron activity: a model for predicting therapeutic efficacy and side effects. Psychopharmacol Ser 3:225-235.
13. Grace AA. 1992. The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J Neural Transm 36 (Suppl):91-131
14. Grace AA, Bunney BS. 1984. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890.
15. Grace AA, Bunney BS. 1986. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092-1100.
16. Hand TH, Hu XT, Wang RY. 1987a. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental area (A10) and nigrostriatal (A9) dopamine neurons. Brain Res 415:257-269.
17. Hand TH, Hu XT, Wang RY. 1987b. Differential effects of typical and atypical antipsychotic drugs on the activity of dopamine neurons and their postsynaptic target cells. In: Chiodo LA, Freeman AS, editors. Neurophysiology of dopaminergic systems: current status and clinical perspectives. Detroit: Lakeshore. p 141-163.
18. 1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. Synapse 30:172-180.
19. 1A receptors and their modulation of the activity of serotonergic and dopaminergic neurones in rats. J Pharmacol Exp Ther 280:1241-1249.
20. 3 receptor antagonist, on spontaneously active midbrain dopamine cells. Eur J Pharmacol 209: 151-156.
21. B receptor antagonist L-365,260, reverses the effects of chronic haloperidol and clozapine on midbrain dopamine neurons in the rat. Brain Res 549:151-154.
22. Minabe Y, Ashby Jr CR, Wang RY. 1992. The effect of acute and chronic granisetron alone or in combination with haloperidol on midbrain dopamine neurons in the rat. Eur Neuropsychopharm 2:127-133.
23. 2 receptor antagonist SR48968 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study. Synapse 25:196-204.
24. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
25. Pazos A, Palacios JM. 1985. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230.
26. 1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12:440-453.
27. 3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons. Eur J Pharmacol 205:113-116.
28. Rasmussen K, Stockton ME, Czachura JF, Howbert JJ. 1991b. Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity. Eur J Pharmacol 209:135-138.
29. 1A receptor antagonist: WAY-405. Soc Neurosci Abstr 25:144.1.
30. Skarsfeldt T. 1988. Differential effects after repeated administration with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopaminergic neurons. Life Sci 42:1037-1044.
31. Skarsfeldt T. 1994. Comparison of short-term administration of sertindole, clozapine and haloperidol on the inactivation of dopamine neurons in the rat. Eur J Pharmacol 254:291-294.
32. Souto M, Monti JM, Altier H. 1979. Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons. Pharmacol Biochem Behav 10:5-9.
33. Wang RY. 1981. Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res Rev 3:123-140.
34. 6 with neuropeptides in rat striatum. J Comp Neurol 370:405-414.
35. White FJ, Wang RY. 1983. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 225:1054-1057.